![Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial | SpringerLink Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10557-021-07212-z/MediaObjects/10557_2021_7212_Fig1_HTML.png)
Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial | SpringerLink
![Safety Spotlight: Omega-3 fatty acid supplementation can increase the risk of atrial fibrillation | Study Deep Dives Safety Spotlight: Omega-3 fatty acid supplementation can increase the risk of atrial fibrillation | Study Deep Dives](https://a99d9b858c7df59c454c-96c6baa7fa2a34c80f17051de799bc8e.ssl.cf1.rackcdn.com/products/nerd/dd81v2Safety%20Spotlight_01.png)
Safety Spotlight: Omega-3 fatty acid supplementation can increase the risk of atrial fibrillation | Study Deep Dives
![Not all omega-3 supplements are created equal, at least in terms of CVD risk reduction', says new study Not all omega-3 supplements are created equal, at least in terms of CVD risk reduction', says new study](https://www.nutraingredients-usa.com/var/wrbm_gb_food_pharma/storage/images/5/9/6/3/1793695-1-eng-GB/Not-all-omega-3-supplements-are-created-equal-at-least-in-terms-of-CVD-risk-reduction-says-new-study.jpg)
Not all omega-3 supplements are created equal, at least in terms of CVD risk reduction', says new study
![Linking omega-3 fatty acid requirements for physiological and clinical... | Download Scientific Diagram Linking omega-3 fatty acid requirements for physiological and clinical... | Download Scientific Diagram](https://www.researchgate.net/profile/Peter-Mclennan-2/publication/261373619/figure/fig1/AS:457447698636801@1486075438429/Linking-omega-3-fatty-acid-requirements-for-physiological-and-clinical-endpoints-with.png)
Linking omega-3 fatty acid requirements for physiological and clinical... | Download Scientific Diagram
![IJMS | Free Full-Text | Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020 | HTML IJMS | Free Full-Text | Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020 | HTML](https://www.mdpi.com/ijms/ijms-21-01362/article_deploy/html/images/ijms-21-01362-g001.png)
IJMS | Free Full-Text | Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020 | HTML
![Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review | SpringerLink Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-019-01211-1/MediaObjects/12325_2019_1211_Fig3_HTML.png)
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review | SpringerLink
![Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management | European Journal of Clinical Nutrition Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management | European Journal of Clinical Nutrition](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fejcn.2013.197/MediaObjects/41430_2013_Article_BFejcn2013197_Fig1_HTML.jpg)
Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management | European Journal of Clinical Nutrition
![Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial | Cardiovascular Diabetology | Full Text Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-019-0887-0/MediaObjects/12933_2019_887_Fig1_HTML.png)
Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial | Cardiovascular Diabetology | Full Text
![American College of Cardiology on Twitter: "ICYMI: The ASCEND Omega-3 trial showed that dietary supplementation with omega-3 fatty acids did not prevent major adverse cardiovascular events. https://t.co/pb1YXwsC9X #ESCCongress #Diabetes @DLBHATTMD ... American College of Cardiology on Twitter: "ICYMI: The ASCEND Omega-3 trial showed that dietary supplementation with omega-3 fatty acids did not prevent major adverse cardiovascular events. https://t.co/pb1YXwsC9X #ESCCongress #Diabetes @DLBHATTMD ...](https://pbs.twimg.com/media/DpUi5nvW0AE3bWQ.jpg)